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Abstract
Introduction: All infants born to HIV-positive mothers have maternal HIV antibodies, sometimes persistent for 18 months.
When Polymerase Chain Reaction (PCR) is not available, August 2006 World Health Organization (WHO) recommendations
suggest that clinical criteria may be used for starting antiretroviral treatment (ART) in HIV seropositive children ,18 months.
Predictors are at least two out of sepsis, severe pneumonia and thrush, or any stage 4 defining clinical finding according to
the WHO staging system.
Methods and Results: From January 2005 to October 2006, we conducted a prospective study on 236 hospitalized children
,18 months old with a positive HIV serological test at the national reference hospital in Kigali. The following data were
collected: PCR, clinical signs and CD4 cell count. Current proposed clinical criteria were present in 148 of 236 children
(62.7%) and in 95 of 124 infected children, resulting in 76.6% sensitivity and 52.7% specificity. For 87 children (59.0%),
clinical diagnosis was made based on severe unexplained malnutrition (stage 4 clinical WHO classification), of whom only 44
(50.5%) were PCR positive. Low CD4 count had a sensitivity of 55.6% and a specificity of 78.5%.
Conclusion: As PCR is not yet widely available, clinical diagnosis is often necessary, but these criteria have poor specificity
and therefore have limited use for HIV diagnosis. Unexplained malnutrition is not clearly enough defined in WHO
recommendations. Extra pulmonary tuberculosis (TB), almost impossible to prove in young children, may often be the cause
of malnutrition, especially in HIV-affected families more often exposed to TB. Food supplementation and TB treatment
should be initiated before starting ART in children who are staged based only on severe malnutrition.
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Introduction
Half of human immunodeficiency virus (HIV) infected children
in resource limited countries will die before 2 years of age if
antiretroviral treatment (ART) is not available [1]. Without
polymerase chain reaction (PCR), early diagnosis of HIV in young
children is a real challenge, as all infants born to HIV positive
mothers have maternal HIV antibodies crossing the placental
barrier, sometimes persisting up to the age of 18 months [2].
Definitive diagnosis of HIV infection is only possible using
advanced technical approaches such as PCR to confirm presence
of the virus in the blood [3]. In recent years, HIV PCR (DNA or
RNA) has become more accessible for resource limited countries:
blood specimen sampling, storage and transport have been
simplified with the use of dried blood spot [4] and prices are
decreasing with the introduction of real time PCR [5]. However,
the equipment remains expensive and requires highly trained
laboratory technicians. Other diagnostic techniques are being
developed, such as detection of immune-complex dissociated P24,
but have not been widely applied or validated [6]. In the
immediate future, HIV PCR will not be available throughout most
resource limited countries. The possibility of treating children
having positive clinical signs and a positive HIV serological test,
without the obligation of doing PCR is an important opportunity
[7], preventing children from dying in places where ART is
already available and free of charge, but where diagnostic PCR is
not. These problems primarily affect African countries, and
420 000 children are newly infected every year worldwide [8].
In December 2004, the World Health Organisation (WHO) first
proposed using clinical criteria to diagnose HIV infection and to
recommend ART for children under 18 months old, first as Web-
based drafts, and finally reported as the 2005 WHO clinical
staging system [9]. The criteria proposed considering a child less
than 18 months old infected if a HIV serological test was positive
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clinical signs were present: sepsis, severe pneumonia, thrush or
severe malnutrition. At the Toronto 2006 AIDS conference, a
sensitivity of 68.8% and a specificity of 74.1% for HIV infection
were reported using these criteria [10].
Criteria were slightly modified in the latest paediatric WHO
guidelines published in August 2006 [11] after the Toronto
conference, but specificity and sensitivity have not yet been
evaluated and were not modified by the latest WHO technical
group which met in Geneva in April 2008 [12]. At this meeting, an
important decision was made to initiate ART for all HIV infected
or clinically suspected (according to the criteria evaluated in this
article) children under the age of one year.
These 2006 criteria suggest that ART should be initiated if HIV
seropositive children ,18 months have two or more of the
following clinical signs: sepsis, severe pneumonia, thrush or any
WHO stage 4 clinical signs (Box S1).
Immune depression indicated by CD4 ,25% for children #11
months old, and CD4 ,20% for children between 12 and 18
months is also a factor for diagnosis of HIV infection apart from
clinical criteria [11].
This study intends to compare the latest WHO (August 2006)
clinical and immunological criteria for HIV infection in children
less than 18 months with previous criteria, as well as to evaluate
the sensitivity and specificity of low CD4 cell counts for HIV
diagnosis, all with HIV PCR (DNA) as the gold standard.
We also discuss recommendations to improve the specificity of
these indispensable clinical scores, since universal access to PCR
remains far from reality.
Materials and Methods
In this prospective study we included all HIV seropositive
children ,18 months old admitted between January 2005 and
December 2007 to the paediatric ward of the ‘‘Centre Hospitalier
Universitaire de Kigali’’ (CHUK), a national reference teaching
hospital in Rwanda. Serostatus was analyzed with a first positive
serological rapid test (First Response, PMC Medical, Daman,
India), and confirmed with a second rapid test (Unigold, Trinity
Biotech plc, Wicklow, Ireland). In the case of discordant results, a
third rapid test (Capillus, Trinity Biotech plc, Wicklow, Ireland)
was added. The following data were collected: DNA PCR
(Amplicor version 1.5, Roche Molecular Systems, Pleasanton,
CA), clinical signs, and absolute and/or relative CD4 cell count. In
the case of lack of reagents or other logistical problems, blood was
preserved in order to collect all data on a single day. Each child
was considered only once, even if hospitalised several times.
Until July 2005, absolute CD4 cell counts were measured with a
Cyflow counter (Partec, Munster, Germany). Relative CD4 cell
counts were estimated by the following algorithm: CD4
,1500=CD4 ,25% for children #11 months old, and CD4
,750=CD4 ,20% for children between 12 and 18 months old [11].
Starting in August 2005, absolute and relative CD4 cell counts
were done with FACSCalibur (BD Bioscience, Becton, Dickinson
and company, USA).
Severe malnutrition was determined as weight for age #3Z
scores (WHO international weight and length charts [13] ) or
weight for height ,70% [14]. AIDS-defining opportunistic
infections (stage 4) were prospectively recorded (Box S2). Sepsis
was diagnosed by the presence of fever and at least two of the
following clinical signs: pulse .180/minute, respiratory rate .40/
minute, capillary refill .3 seconds. Oxygen, IV antibiotics and
volume expansion were given. The diagnosis of severe pneumonia
was based on chest X-ray and oxygen requirement. Definition of
oral candidiasis (thrush) relied on clinical observation of white
creamy small plaques in the mouth [11].
Clinical values and immunological results were compared to the
results of PCR, which has reported 98% sensitivity and specificity
for infected children after the age of four weeks [15]. For statistical
analyses we relied on Microsoft Office Excel 2003 (Microsoft
Corporation, Redmond, Washington) and SPSS (SPPS inc. 14.0.0,
Chicago, Illinois).
We received ethical approval for this study from the Research
Board of CHUK, recognized by the national ethical committee.
Only interventional studies or studies requiring examinations not
included in routine work-up would have required referral to the
national ethics committee. All hospitalized children in Rwanda are
offered routine HIV testing after counselling of parents or legal
guardians; no written consent is performed. This corresponds to
Rwanda’s national recommendations for scaling-up of HIV testing
of children. For collecting these data, no additional blood samples
or extra physical examinations were performed. The analyses of
these data are done with identification numbers corresponding to
each patient to preserve patient anonymity.
Results
Two hundred and thirty six children matched the study
inclusion criteria; 105 children were female, 131 were male, and
the median age was 9 months (20 days to 18 months old). 124 of
236 (52.5%) of children were confirmed to be infected with HIV
using HIV DNA PCR (Table 1). Half of the children (123/236,
52.1%) had severe unexplained malnutrition corresponding to
WHO clinical stage 4 (Box S2), whereas septicaemia, pneumonia
or thrush were present in 28.0%, 42.0% and 36.0% respectively.
Seventy nine percent of children were in WHO stage 3 or 4, and
39.4% had low CD4 cell counts (Table 1).
Logistic regression of predictors for HIV infection in children
,18 months showed significance for WHO clinical criteria, CD4
cell counts and age, but not for sex (Table 2). One hundred and
forty eight children (62.7%) displayed WHO 2006 clinical HIV-
defining criteria, of which 87 (58.7%) met 2006 criteria based on
unexplained severe malnutrition alone. Only 44 (50.5%) of these
severely malnourished children were PCR positive.
Table 1. Characteristics of 236 hospitalized children under 18
months old with an HIV-1 serological positive test in Rwanda.
Characteristics
(N=236) Proportion or mean %
Gender (M/F) 131/105 55.5/44.5
Average age 9 months (range 20 days-18 months)
HIV PCR positive 124 52.5
WHO clinical stage I* 27 11.4
WHO clinical stage II 22 9.3
WHO clinical stage III 57 24.2
WHO clinical stage IV 130 55.1
Severe malnutrition 123 52.1
Septicemia 66 28
Thrush 85 36
Pneumonia 99 41.9
low CD4 cell count 93 39.4
*ref [11].
doi:10.1371/journal.pone.0005312.t001
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specificity of 52.7%.
Using 2005 interim WHO clinical criteria would have resulted
in a sensitivity of 68.5% and a specificity of 71.4% (Table 3). Low
CD4 cell counts had a sensitivity of 55.6% and a specificity of
78.5%, with a positive predictive value (PPV) of 74.2% and a
negative predictive value (NPV) of 61.5%. Combining clinical
criteria with CD4 cell count resulted in sensitivity of 88.7% and
specificity of 42.9%, and combining them with age .12 months
gave sensitivity of 83.9% and specificity of 45.5% (Table 3).
McNemar testing of differences in sensitivities and specificities
showed significance for all paired comparisons.
Discussion
This study evaluated the revised WHO algorithm for predicting
HIV infection in children under 18 months old. Comparing the
WHO 2005 interim clinical presumptive diagnosis guidelines with
the August 2006 guidelines, the new guidelines gained in sensitivity
but lost in specificity, mainly due to the inclusion of severe
unexplained malnutrition as a stage 4-defining criterion, for which
ART is recommended. More HIV uninfected children risk
incorrectly receiving ART because of ‘‘unexplained malnutrition’’.
Many of these infants are also exposed to poverty and tuberculosis
(TB), conditions that also lead to malnutrition [16–18] .
CD4 cell count and total lymphocyte count are known to have a
low sensitivity for HIV infection; this was also observed for CD4
cell counts in our cohort. Low CD4 cell counts and low total
lymphocyte counts are known markers of progression leading to
mortality in resource–rich countries [19] and have already been
evaluated as markers indicating need to start ART in resource
limited countries [20] but have not been evaluated as markers of
infection for children under 18 months old. We did not include the
evaluation of low lymphocyte count in this study given the
extremely low predictive value found hitherto. The method of
extrapolation of CD4 cell percentage based on absolute CD4 cell
count risks misclassification of children with lymphopenia or
lymphocytosis. Severe malnutrition can also influence CD4 cell
values and could have an effect on the predictive value of CD4 cell
counts for HIV infection, as 52.1% of our children were severely
malnourished.
Adding CD4 cell count to the WHO clinical criteria increases
the sensitivity of HIV diagnosis, but lowers the specificity
considerably. This study shows that an alternative: adding
persistent anti-HIV antibodies at ages over 12 months as a
predictor, also increases sensitivity and lowers specificity, but to a
minor degree (Table 3).
Could the study’s setting in a reference hospital have influenced
the results, making them difficult to apply to other situations? The
population of children hospitalized at a tertiary level is generally
more seriously ill, increasing the sensitivity of the clinical scores.
But university and other reference hospitals in developing
countries almost always also serve as district hospitals for the city;
only a minority of the patients was truly referred in 2005. In
addition, the country’s poverty could have had the same effect, but
WHO guidelines were conceived for countries where PCR is not
available, which are mainly poor to very poor settings.
One important confounding factor for clinical diagnosis of HIV
in children is tuberculosis, as children born into HIV-affected
families are more frequently exposed to TB [21]. Young children
infected with TB can be stunted, with malnutrition-related
immune depression clinical signs including sepsis, thrush and
pneumonia, and may also be anergic to PPD [22]. Malnourished
children also have severe cellular immunodeficiency [23].
Tuberculosis is extremely difficult to diagnose in young children
[24], and disseminated and extra-pulmonary tuberculosis occur
more frequently than in adults [25]. Mycobacterium blood
culture, PCR, and bronchoalveolar lavage and cultures are rarely
available in resource limited settings. Moreover, the yield of
microscopic examination of gastric fluid samples for acid fast
bacilli is low (5 to 10%) [26] even when advanced laboratory tests
are available. Children with severe malnutrition do not present
with classic inflammatory signs of tuberculosis infection [27] such
as cough, fever, enlarged lymph nodes and positive X-rays [28]. A
Table 2. Logistic regression of individual predictors for HIV
infection in children ,18 months.
Variables in the Equation
B S.E. Wald df Sig. Exp (B)
Age 0.127 0.036 12.627 1 0.000 1.135
Sex 20.157 0.332 0.225 1 0.635 0.855
Malnutrition 0.386 0.186 4.299 1 0.038 1.471
Septicemia 0.956 0.381 6.290 1 0.012 2.600
Pneumonia 1.249 0.338 13.690 1 0.000 3.487
Thrush 1.518 0.363 17.485 1 0.000 4.564
CD4 cell count 1.402 0.347 16.351 1 0.000 4.065
Constant 23.237 0.570 32.296 1 0.000 0.039
Hosmer and Lemeshow: 0.469.
doi:10.1371/journal.pone.0005312.t002
Table 3. Sensitivity and specificity of different WHO presumptive diagnostic alternatives of HIV infection in children ,18 months
with a positive serological test for HIV in Rwanda.
Criteria Sensitivity (CI) Specificity (CI) PPV NPV
Interim WHO 2005 68.5 (59.6–76.6) 71.4 (62.1–79.6) 72.6 67.2
WHO 2006 76.6 (68.2–83.7) 52.7 (43–62.2) 64.1 67
Low CD4 cell count 55.6 (46.5–64.6) 78.5 (69.8–85.8) 74.1 61.4
WHO 2006 plus age .12 months 83.9 (76.2–89.9) 45.5 (36.1–55.2) 63 71.8
WHO 2006 plus CD4 cell count 88.7(81.8–93.8) 42.9 (33.5–52.6) 63.2 77.4
CI: confidence intervals.
PPV: positive predictive value.
NPV: negative predictive value.
doi:10.1371/journal.pone.0005312.t003
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tuberculosis has been reported [29].
Clinical scores and empiric TB treatment are not described in
the WHO definition for unexplained malnutrition. Without clearly
defining a method for excluding TB, ‘‘unexplained’’ stunting will
be overestimated. In countries where the epidemics of tuberculosis
and HIV exist concurrently, confusion between the two diseases
will continue to be a reality [30]. Treating HIV with ART without
first initiating TB treatment in children harbouring both infections
can lead to fulminant tuberculosis as part of immune reconstitu-
tion inflammatory syndrome. Worse, treating an HIV suspected
but actually HIV negative child with ART bears the risk of
overlooking TB as the true diagnosis [31].
Future research could evaluate the following strategy, in use in
Rwanda since this study: Children under 18 months old with a
positive HIV serological test, who meet WHO criteria for
initiating ART based only on severe unexplained malnutrition,
should be started for one month on food supplementation and
empiric TB treatment. Initiation of ART could then be based on
the child’s response to these interventions to exclude malnutrition
due to food insufficiency and TB.
Based on the results of the CHER study [32], WHO recently
[12] recommended systematic ART for all infected or even
clinically suspected children under 12 months if PCR is not
available, irrespective of CD4 or clinical stage [32]. This study
demonstrated lower overall mortality in the ART group.
As clinicians, we hope to be able to continue saving children’s
lives, even when lacking the technology for clinical diagnosis. We
should evaluate the clinical response to food supplementation and
empiric TB treatment, and validate clinical scoring using this
algorithm, to improve the specificity of actual HIV clinical signs.
In the meantime, scaling up access to HIV PCR testing is urgently
needed.
Using revised August 2006 WHO criteria for diagnosis of HIV
infection in children under 18 months results in a 53.6%
specificity, 17.7% lower than the 2005 WHO clinical guidelines,
merely due to the acceptance of unexplained severe malnutrition
as a single criterion defining stage 4 HIV infection. Although 3/4
of infected children were detected by clinical criteria alone, we
would have treated 46.4% of uninfected children without the
availability of PCR. Beyond the cost and risks of treating
uninfected children, this also may lead clinicians to fail to diagnose
other existing conditions, especially TB.
The low diagnostic accuracy of these clinical criteria and of
CD4 cell count emphasizes the urgent need for availability of HIV
PCR testing in low resource countries and for better diagnostic
tools for tuberculosis in young children.
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